Poinciana Advisors Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
202
-43
-18% -$43.9K 0.18% 92
2026
Q1
$225K Buy
245
+43
+21% +$43.6K 0.18% 112
2025
Q4
$217K Buy
+202
New +$193K 0.17% 122
2025
Q2
Sell
-440
Closed -$363K 135
2025
Q1
$363K Buy
+440
New +$366K 0.38% 42

Other funds holding LLY

Poinciana Advisors Group's LLY Position: Q2 2026 in Review

Poinciana Advisors Group reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $43.9K and leaving 202 shares worth $242K. The position accounts for 0.18% of the portfolio, ranked #92.

Poinciana Advisors Group first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. The position peaked at $363K in Q1 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Poinciana Advisors Group held 202 shares of Eli Lilly worth $242K as of Q2 2026.
  • Poinciana Advisors Group sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.18% of Poinciana Advisors Group's portfolio in Q2 2026, its #92 holding.
  • Poinciana Advisors Group first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
  • Poinciana Advisors Group's Eli Lilly position peaked at $363K in Q1 2025.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Poinciana Advisors Group's 13F filing for Q2 2026, filed 28 Jul 2026.